Red Cross and Armed Services Blood Program Launch Partnership to Strengthen Military and Civilian Blood Supply
Honor the spirit of Independence Day by rolling up a sleeve to give blood WASHINGTON, July 1, 2025 /PRNewswire/ — In a powerful show of unity and commitment... Read more.
Sobi to amend existing agreement with Apellis for ex-U.S. royalties of Aspaveli® (systemic pegcetacoplan)
STOCKHOLM, July 1, 2025 /PRNewswire/ — Sobi® (STO: SOBI), today announced a capped royalty purchase agreement with Apellis Pharmaceuticals, Inc. under which... Read more.
The Shyft Group and Aebi Schmidt Group Announce Successful Completion of Merger, Creating Global Specialty Vehicle Leader
Combined company named Aebi Schmidt Group Trading on NASDAQ expected to begin July 1, 2025 Shyft common stock delisted from Nasdaq NOVI, Mich., July 1, 2025 /PRNewswire/... Read more.
Trevi Therapeutics to Attend Leerink Partners Therapeutics Forum: I&I and Metabolism
NEW HAVEN, Conn., July 1, 2025 /PRNewswire/ — Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational... Read more.
Alphyn’s Zabalafin Hydrogel for Atopic Dermatitis Highlighted in Leading Peer-Reviewed Journal
Expert dermatologist panel creates new atopic dermatitis (AD) algorithm (stepped diagnosis and treatment recommendations) emphasizing need for therapeutics that... Read more.
Soligenix Announces Synthetic Hypericin Successfully Manufactured at Sterling Pharma Solutions
Active Ingredient Manufacturing Transfer to the U.S. Complete PRINCETON, N.J., July 1, 2025 /PRNewswire/ — Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or... Read more.
Broadridge Announces Expanded Roles for Senior Leaders
Doug DeSchutter and Tom Carey to take on new responsibilities NEW YORK, July 1, 2025 /PRNewswire/ — Broadridge Financial Solutions, Inc. (NYSE: BR), a global... Read more.
Will Tariff-Induced Supply Chain Unpredictability Grinch-ify ‘Christmas in July’?
UT Haslam supply chain expert weighs how tariffs may affect Amazon Prime Day and other July sales events. KNOXVILLE, Tenn., July 1, 2025 /PRNewswire/ — In... Read more.
Nektar Therapeutics Announces Pricing of $100 Million Public Offering
SAN FRANCISCO, July 1, 2025 /PRNewswire/ — Nektar Therapeutics (Nasdaq: NKTR), a clinical-stage biotechnology company focused on the development of innovative... Read more.
ePlus Closes Sale of Financing Business to PEAC Solutions
HERNDON, Va., July 1, 2025 /PRNewswire/ — ePlus inc. (NASDAQ NGS: PLUS – news) today announced that it has closed on the sale of its U.S. financing business... Read more.